Our previous study has shown that KDM2A promotes angiogenesis, maintains cancer stemness, and induces drug resistance in breast cancer by regulating jagged-1(JAG-1) and SRY-box transcription factor 2 (SOX-2). This evidence concerns the gene KDM2A and breast carcinoma.